Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio J Sanchez-Barcelo

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery|December 31, 2013
Recent patents on light based therapies: photodynamic therapy, photothermal therapy and photoimmunotherapyEmilio J Sanchez-Barcelo, Maria D Mediavilla
Breast Cancer Research and Treatment|July 2, 2008
Role of melatonin in the epigenetic regulation of breast cancerAhmet Korkmaz, Emilio J Sanchez-Barcelo, Dun-Xian Tan, et al.
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery|February 29, 2012
Breast cancer therapy based on melatoninEmilio J Sanchez-Barcelo, Maria D Mediavilla, Carolina Alonso-Gonzalez, et al.
Journal of Pineal Research|April 29, 2016
Constitutive photomorphogenesis protein 1 (COP1) and COP9 signalosome, evolutionarily conserved photomorphogenic proteins as possible targets of melatoninEmilio J Sanchez-Barcelo, Maria D Mediavilla, Jerry Vriend, et al.
Expert Opinion on Investigational Drugs|April 17, 2012
Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiationEmilio J Sanchez-Barcelo, Maria D Mediavilla, Carolina Alonso-Gonzalez, et al.
Current Medicinal Chemistry|July 20, 2017
Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural DisordersEmilio J Sanchez-Barcelo, Noemi Rueda, María D Mediavilla, et al.
Toxicology Letters|August 30, 2008
Melatonin modulates the cadmium-induced expression of MT-2 and MT-1 metallothioneins in three lines of human tumor cells (MCF-7, MDA-MB-231 and HeLa)Carolina Alonso-Gonzalez, Dolores Mediavilla, Carlos Martinez-Campa, et al.
Cancer Letters|May 16, 2008
Melatonin down-regulates hTERT expression induced by either natural estrogens (17beta-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cellsCarlos M Martínez-Campa, Carolina Alonso-González, Maria D Mediavilla, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery|December 31, 2013
Recent patents on light based therapies: photodynamic therapy, photothermal therapy and photoimmunotherapyEmilio J Sanchez-Barcelo, Maria D Mediavilla
Breast Cancer Research and Treatment|July 2, 2008
Role of melatonin in the epigenetic regulation of breast cancerAhmet Korkmaz, Emilio J Sanchez-Barcelo, Dun-Xian Tan, et al.
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery|February 29, 2012
Breast cancer therapy based on melatoninEmilio J Sanchez-Barcelo, Maria D Mediavilla, Carolina Alonso-Gonzalez, et al.
Journal of Pineal Research|April 29, 2016
Constitutive photomorphogenesis protein 1 (COP1) and COP9 signalosome, evolutionarily conserved photomorphogenic proteins as possible targets of melatoninEmilio J Sanchez-Barcelo, Maria D Mediavilla, Jerry Vriend, et al.
Expert Opinion on Investigational Drugs|April 17, 2012
Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiationEmilio J Sanchez-Barcelo, Maria D Mediavilla, Carolina Alonso-Gonzalez, et al.
Current Medicinal Chemistry|July 20, 2017
Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural DisordersEmilio J Sanchez-Barcelo, Noemi Rueda, María D Mediavilla, et al.
Toxicology Letters|August 30, 2008
Melatonin modulates the cadmium-induced expression of MT-2 and MT-1 metallothioneins in three lines of human tumor cells (MCF-7, MDA-MB-231 and HeLa)Carolina Alonso-Gonzalez, Dolores Mediavilla, Carlos Martinez-Campa, et al.
Cancer Letters|May 16, 2008
Melatonin down-regulates hTERT expression induced by either natural estrogens (17beta-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cellsCarlos M Martínez-Campa, Carolina Alonso-González, Maria D Mediavilla, et al.
Pageof 1